Bodal Chemicals FY26 Net Profit Jumps 158% to 478.3M Rupees
Bodal Chemicals reported a consolidated net profit of 478.28 million rupees for FY26, a 158.5% increase from the previous year. Q4 net profit rose to 320.60 million rupees, with total income growing to 5,906.03 million rupees.

*this image is generated using AI for illustrative purposes only.
Bodal Chemicals has released its audited standalone and consolidated financial results for the financial year ended March 31, 2026. The company reported a consolidated net profit of 478.28 million rupees for FY26, a significant increase of 158.5% compared to 185.02 million rupees in the previous year. On a standalone basis, net profit for the year stood at 470.44 million rupees, rising from 195.78 million rupees in FY25. The growth was driven by improved volumes, better realizations, and the recognition of SGST incentive income from the Punjab government.
Operational Performance
The company achieved a total consolidated income of 20,538.90 million rupees in FY26, a growth of 16.9% year-on-year. For the fourth quarter ended March 31, 2026, consolidated net profit was 320.60 million rupees, compared to 145.04 million rupees in the corresponding quarter of the previous year. Quarterly income rose to 5,906.03 million rupees from 4,532.22 million rupees. The consolidated EBITDA for Q4 FY26 stood at 711.5 million rupees, a 43.4% increase, with margins improving to 12.0% from 10.9% in the year-ago quarter.
Segment Performance
Revenue from Dye intermediates grew by 6%, Dyestuff grew by 6%, and Basic Chemicals grew by 80% on a YoY basis during FY26. In Q4 FY26, Revenue from Dye Intermediates stood at 1,936 million rupees, growing by 21% YoY, while Revenue from Dyestuffs stood at 1,441 million rupees, a growth of 15% YoY. Revenue from Basic Chemicals stood at 632 million rupees, growing by 239% YoY, driven by a rise in raw material prices such as Sulphur and an increase in finished goods prices. The Chlor Alkali business reported revenue of 3,387 million rupees for FY26, remaining in line with the previous year.
Strategic Decisions
The Board of Directors approved the sale of Unit I, located at GIDC, Vatva, Ahmedabad, as the unit was inoperative and not significant in terms of revenue. The management's ongoing rationalisation and monetisation of non-core assets has helped to maintain cashflow and profitability. Additionally, the company noted that the Benzene downstream products at the Saykha plant achieved satisfactory production levels, though margins remain under pressure due to intense competition and subdued demand.
Key Financial Metrics
The following table summarizes the consolidated financial performance for the year and quarter ended March 31, 2026:
| Metric: | Year Ended 31.03.2026 | Year Ended 31.03.2025 | Quarter Ended 31.03.2026 | Quarter Ended 31.03.2025 |
|---|---|---|---|---|
| Net Profit: | 478.3M Rupees | 185.0M Rupees | 320.6M Rupees | 145.0M Rupees |
| Revenue from Operations: | 20,122.4M Rupees | 17,484.3M Rupees | 5,880.2M Rupees | 4,508.7M Rupees |
| Total Income: | 20,538.9M Rupees | 17,567.2M Rupees | 5,906.0M Rupees | 4,532.2M Rupees |
| Basic EPS (Rs.): | 3.8 | 1.5 | 2.6 | 1.2 |
Revenue from operations included SGST incentive income of 269.80 million rupees recognized under the Punjab Industrial Incentive Scheme. The company also recognized exceptional items of 0.3 million rupees for the year related to a fire incident at Unit 7.
Historical Stock Returns for Bodal Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.86% | +6.51% | +9.84% | +34.74% | -3.93% | -34.16% |
How will Bodal Chemicals deploy the proceeds from the sale of Unit I at GIDC Vatva, and are there additional non-core assets being considered for monetization?
Given the 239% YoY surge in Basic Chemicals revenue driven by rising Sulphur prices, how vulnerable is Bodal Chemicals to a potential reversal in raw material price cycles in FY27?
Will the SGST incentive income from the Punjab government's Industrial Incentive Scheme continue to be recognized in FY27, and what is the expected duration and total value of this benefit?


































